RYR2 and catecholaminergic polymorphic ventricular tachycardia: Approximately 50% of CPVT cases stem from autosomal dominant, gain‐of‐function mutations in the cardiac ryanodine receptor (RYR2, OMIM accession 180902) gene (Behere and Weindling 2016).